140 related articles for article (PubMed ID: 37749069)
1. Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode.
Amsterdam JD; Xu C
Bipolar Disord; 2024 May; 26(3):255-264. PubMed ID: 37749069
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
[TBL] [Abstract][Full Text] [Related]
3. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
4. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
Amsterdam JD; Wang G; Shults J
Acta Psychiatr Scand; 2010 Mar; 121(3):201-8. PubMed ID: 19694630
[TBL] [Abstract][Full Text] [Related]
6. Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial.
Lorenzo-Luaces L; Amsterdam JD
Psychiatry Res; 2018 Jan; 259():455-459. PubMed ID: 29136600
[TBL] [Abstract][Full Text] [Related]
7. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
Br J Psychiatry; 2016 Apr; 208(4):359-65. PubMed ID: 26892848
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2010 Jun; 30(3):306-11. PubMed ID: 20473068
[TBL] [Abstract][Full Text] [Related]
10. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Amsterdam JD; Shults J
J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
Amsterdam JD; Shults J
Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
Amsterdam JD; Shults J
Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
15. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Altshuler LL; Post RM; Hellemann G; Leverich GS; Nolen WA; Frye MA; Keck PE; Kupka RW; Grunze H; McElroy SL; Sugar CA; Suppes T
J Clin Psychiatry; 2009 Apr; 70(4):450-7. PubMed ID: 19358785
[TBL] [Abstract][Full Text] [Related]
16. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.
Gao K; Kemp DE; Ganocy SJ; Muzina DJ; Xia G; Findling RL; Calabrese JR
Bipolar Disord; 2008 Dec; 10(8):907-15. PubMed ID: 19594506
[TBL] [Abstract][Full Text] [Related]
17. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.
Amsterdam JD; Shults J; Brunswick DJ; Hundert M
Bipolar Disord; 2004 Feb; 6(1):75-81. PubMed ID: 14996144
[TBL] [Abstract][Full Text] [Related]
18. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.
Lorenzo-Luaces L; Amsterdam JD; Soeller I; DeRubeis RJ
Acta Psychiatr Scand; 2016 Jun; 133(6):459-69. PubMed ID: 26803764
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
[TBL] [Abstract][Full Text] [Related]
20. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
Ghaemi SN; Goodwin FK
J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
